S6 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

Subjects:

S5 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

Subjects:

ROC curve analysis for the predictive power of biomarkers for distinguishing between patients with Omicron variant and healthy controls. by Feng Gao (3548)

Subjects:

Analysis of the correlation between pharyngeal microbiomics, metabolomics and clinical indicators between OC and HC. by Feng Gao (3548)

Subjects:

Changes in soil three-phase structure distance (STPSD) and generalized soil structure index (GSSI) before and after the experiment. by Hongyi Pan (5706971)

Subjects:

Changes in root morphology indexes and root dry weight of different treatments in September 2023 (Second planting). by Hongyi Pan (5706971)

Subjects:

Metabolome KEGG enrichment analysis of serum in Omicron variant cases and recovered cases. by Feng Gao (3548)

Subjects:

Relationship between soil three phases and ideal points in different treatments before and after the experiment. by Hongyi Pan (5706971)

Subjects:

Untargeted metabolomic profiling of sera from Omicron variant cases of the discovery cohort. by Feng Gao (3548)

Subjects:

Changes in average BD, PD, and TP of rhizosphere soil (0–60 cm) under different treatments before and after the experiment. by Hongyi Pan (5706971)

Subjects:

S8 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

Subjects:

AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves. by Naruyoshi Gyoutoku (22537831)

Subjects:

Logistic regression analysis to predict the efficacy for liver function. by Naruyoshi Gyoutoku (22537831)

Subjects:

Comparison in baseline variables between efficacy group and non-efficacy group. by Naruyoshi Gyoutoku (22537831)

Subjects:

Comparison of ALT (A), AST (B), and Fib-4 index (C) before and after imeglimin treatment in ALT ≥ 25 IU/L and ALT < 25IU/L groups. by Naruyoshi Gyoutoku (22537831)

Subjects:

Clinical characteristics at baseline and at the end of the study. by Naruyoshi Gyoutoku (22537831)

Subjects:

Participant flow (CONSORT diagram). by David J. Diemert (8135568)

Subjects:

Demographic and baseline characteristics of study participants by vaccine group. by David J. Diemert (8135568)

Subjects:

Number and percentage of participants experiencing solicited injection site and systemic reactions by maximum severity and vaccine group. by David J. Diemert (8135568)

Subjects:

Effect of 0.1mM salicylic acid (SA) or hydrogen peroxide (H₂O₂) and salt treatment (0 and 75 mM NaCl) on malondialdehyde (MDA) level in shoots (A) and roots (... by Amal Bouallegue (21512298)

Subjects: